QIC Part D
C2C fosters an organizational culture that embraces honesty, integrity and respect. We perform our duties with our corporate values in mind: "Integrity, Quality and Value with PRIDE (Passion for our customers, Responsibility to seek innovative solutions, Initiative to make things better, Discipline to strive for excellence and Enthusiasm for the future)."
We have assembled a workforce inspired by a common purpose of upholding our quality values of “Integrity, Quality & Value driving Continuous Improvement.” Our culture generates our drive to deliver exceptional customer service and commitment to maintaining the highest quality standards. Our team members have in-depth knowledge of health insurance plans including, but not limited to, traditional fee-for-service (FFS) Medicare, Medicare Advantage (Part C) and Medicare Prescription Drug Coverage (Part D) and vast experience managing second level appeals from case receipt to final disposition.
Effective February 1, 2021, C2C Innovative Solutions, Inc. (C2C), is the Part D QIC; therefore, we are adjudicating new reconsideration requests received on and after February 1, 2021. There will be a short period in which both C2C and Maximus, the outgoing QIC, are processing reconsiderations. Maximus will continue posting effectuation, case file submission information, and appeals received/decided for reconsideration requests received on or before January 31, 2021and reopening requests for drug benefit appeals received on or before March 31, 2021 and reopening requests for LEP appeals received on or before April 16, 2021. PDP and MA-PDP Plans should return case files to Maximus, when Maximus has requested the case file.
C2C Innovative Solutions, Inc.
QIC Part D
301 W. Bay St., Suite 600
Jacksonville, FL 32202